Neuromodulators Injectable Market - Global Outlook and Forecast 2021-2027

March 2021 | 91 pages | ID: NF1788C469AEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Neuromodulators Injectable in Global, including the following market information:

Global Neuromodulators Injectable Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Neuromodulators Injectable market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuromodulators Injectable companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neuromodulators Injectable Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Neuromodulators Injectable Market Segment Percentages, By Type, 2020 (%)

• Botulinum Toxin
• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-l-Lactic Acid
• Others

China Neuromodulators Injectable Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Neuromodulators Injectable Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Dermatology Clinics
• Spas and Aesthetic Clinics

Global Neuromodulators Injectable Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Neuromodulators Injectable Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Neuromodulators Injectable Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Neuromodulators Injectable Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• ALLERGAN
• Merz Pharma
• Suneva Medical
• Medytox
• Sinclair Pharma
• Bloomage BioTechnology Corporation Limited
• Anika Therapeutics
• Galderma
• Bausch Health Companies
• Integra Lifesciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neuromodulators Injectable Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neuromodulators Injectable Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROMODULATORS INJECTABLE OVERALL MARKET SIZE

2.1 Global Neuromodulators Injectable Market Size: 2021 VS 2027
2.2 Global Neuromodulators Injectable Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neuromodulators Injectable Players in Global Market
3.2 Top Global Neuromodulators Injectable Companies Ranked by Revenue
3.3 Global Neuromodulators Injectable Revenue by Companies
3.4 Top 3 and Top 5 Neuromodulators Injectable Companies in Global Market, by Revenue in 2020
3.5 Global Companies Neuromodulators Injectable Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuromodulators Injectable Players in Global Market
  3.6.1 List of Global Tier 1 Neuromodulators Injectable Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neuromodulators Injectable Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Neuromodulators Injectable Market Size Markets, 2021 & 2027
  4.1.2 Botulinum Toxin
  4.1.3 Hyaluronic Acid
  4.1.4 Calcium Hydroxylapatite
  4.1.5 Poly-l-Lactic Acid
  4.1.6 Others
4.2 By Type - Global Neuromodulators Injectable Revenue & Forecasts
  4.2.1 By Type - Global Neuromodulators Injectable Revenue, 2016-2021
  4.2.2 By Type - Global Neuromodulators Injectable Revenue, 2022-2027
  4.2.3 By Type - Global Neuromodulators Injectable Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neuromodulators Injectable Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Dermatology Clinics
  5.1.4 Spas and Aesthetic Clinics
5.2 By Application - Global Neuromodulators Injectable Revenue & Forecasts
  5.2.1 By Application - Global Neuromodulators Injectable Revenue, 2016-2021
  5.2.2 By Application - Global Neuromodulators Injectable Revenue, 2022-2027
  5.2.3 By Application - Global Neuromodulators Injectable Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Neuromodulators Injectable Market Size, 2021 & 2027
6.2 By Region - Global Neuromodulators Injectable Revenue & Forecasts
  6.2.1 By Region - Global Neuromodulators Injectable Revenue, 2016-2021
  6.2.2 By Region - Global Neuromodulators Injectable Revenue, 2022-2027
  6.2.3 By Region - Global Neuromodulators Injectable Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Neuromodulators Injectable Revenue, 2016-2027
  6.3.2 US Neuromodulators Injectable Market Size, 2016-2027
  6.3.3 Canada Neuromodulators Injectable Market Size, 2016-2027
  6.3.4 Mexico Neuromodulators Injectable Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Neuromodulators Injectable Revenue, 2016-2027
  6.4.2 Germany Neuromodulators Injectable Market Size, 2016-2027
  6.4.3 France Neuromodulators Injectable Market Size, 2016-2027
  6.4.4 U.K. Neuromodulators Injectable Market Size, 2016-2027
  6.4.5 Italy Neuromodulators Injectable Market Size, 2016-2027
  6.4.6 Russia Neuromodulators Injectable Market Size, 2016-2027
  6.4.7 Nordic Countries Neuromodulators Injectable Market Size, 2016-2027
  6.4.8 Benelux Neuromodulators Injectable Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Neuromodulators Injectable Revenue, 2016-2027
  6.5.2 China Neuromodulators Injectable Market Size, 2016-2027
  6.5.3 Japan Neuromodulators Injectable Market Size, 2016-2027
  6.5.4 South Korea Neuromodulators Injectable Market Size, 2016-2027
  6.5.5 Southeast Asia Neuromodulators Injectable Market Size, 2016-2027
  6.5.6 India Neuromodulators Injectable Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Neuromodulators Injectable Revenue, 2016-2027
  6.6.2 Brazil Neuromodulators Injectable Market Size, 2016-2027
  6.6.3 Argentina Neuromodulators Injectable Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neuromodulators Injectable Revenue, 2016-2027
  6.7.2 Turkey Neuromodulators Injectable Market Size, 2016-2027
  6.7.3 Israel Neuromodulators Injectable Market Size, 2016-2027
  6.7.4 Saudi Arabia Neuromodulators Injectable Market Size, 2016-2027
  6.7.5 UAE Neuromodulators Injectable Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 ALLERGAN
  7.1.1 ALLERGAN Corporate Summary
  7.1.2 ALLERGAN Business Overview
  7.1.3 ALLERGAN Neuromodulators Injectable Major Product Offerings
  7.1.4 ALLERGAN Neuromodulators Injectable Revenue in Global (2016-2021)
  7.1.5 ALLERGAN Key News
7.2 Merz Pharma
  7.2.1 Merz Pharma Corporate Summary
  7.2.2 Merz Pharma Business Overview
  7.2.3 Merz Pharma Neuromodulators Injectable Major Product Offerings
  7.2.4 Merz Pharma Neuromodulators Injectable Revenue in Global (2016-2021)
  7.2.5 Merz Pharma Key News
7.3 Suneva Medical
  7.3.1 Suneva Medical Corporate Summary
  7.3.2 Suneva Medical Business Overview
  7.3.3 Suneva Medical Neuromodulators Injectable Major Product Offerings
  7.3.4 Suneva Medical Neuromodulators Injectable Revenue in Global (2016-2021)
  7.3.5 Suneva Medical Key News
7.4 Medytox
  7.4.1 Medytox Corporate Summary
  7.4.2 Medytox Business Overview
  7.4.3 Medytox Neuromodulators Injectable Major Product Offerings
  7.4.4 Medytox Neuromodulators Injectable Revenue in Global (2016-2021)
  7.4.5 Medytox Key News
7.5 Sinclair Pharma
  7.5.1 Sinclair Pharma Corporate Summary
  7.5.2 Sinclair Pharma Business Overview
  7.5.3 Sinclair Pharma Neuromodulators Injectable Major Product Offerings
  7.5.4 Sinclair Pharma Neuromodulators Injectable Revenue in Global (2016-2021)
  7.5.5 Sinclair Pharma Key News
7.6 Bloomage BioTechnology Corporation Limited
  7.6.1 Bloomage BioTechnology Corporation Limited Corporate Summary
  7.6.2 Bloomage BioTechnology Corporation Limited Business Overview
  7.6.3 Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Major Product Offerings
  7.6.4 Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Revenue in Global (2016-2021)
  7.6.5 Bloomage BioTechnology Corporation Limited Key News
7.7 Anika Therapeutics
  7.7.1 Anika Therapeutics Corporate Summary
  7.7.2 Anika Therapeutics Business Overview
  7.7.3 Anika Therapeutics Neuromodulators Injectable Major Product Offerings
  7.4.4 Anika Therapeutics Neuromodulators Injectable Revenue in Global (2016-2021)
  7.7.5 Anika Therapeutics Key News
7.8 Galderma
  7.8.1 Galderma Corporate Summary
  7.8.2 Galderma Business Overview
  7.8.3 Galderma Neuromodulators Injectable Major Product Offerings
  7.8.4 Galderma Neuromodulators Injectable Revenue in Global (2016-2021)
  7.8.5 Galderma Key News
7.9 Bausch Health Companies
  7.9.1 Bausch Health Companies Corporate Summary
  7.9.2 Bausch Health Companies Business Overview
  7.9.3 Bausch Health Companies Neuromodulators Injectable Major Product Offerings
  7.9.4 Bausch Health Companies Neuromodulators Injectable Revenue in Global (2016-2021)
  7.9.5 Bausch Health Companies Key News
7.10 Integra Lifesciences
  7.10.1 Integra Lifesciences Corporate Summary
  7.10.2 Integra Lifesciences Business Overview
  7.10.3 Integra Lifesciences Neuromodulators Injectable Major Product Offerings
  7.10.4 Integra Lifesciences Neuromodulators Injectable Revenue in Global (2016-2021)
  7.10.5 Integra Lifesciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neuromodulators Injectable Market Opportunities & Trends in Global Market
Table 2. Neuromodulators Injectable Market Drivers in Global Market
Table 3. Neuromodulators Injectable Market Restraints in Global Market
Table 4. Key Players of Neuromodulators Injectable in Global Market
Table 5. Top Neuromodulators Injectable Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Neuromodulators Injectable Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Neuromodulators Injectable Revenue Share by Companies, 2016-2021
Table 8. Global Companies Neuromodulators Injectable Product Type
Table 9. List of Global Tier 1 Neuromodulators Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuromodulators Injectable Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Neuromodulators Injectable Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Neuromodulators Injectable Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Neuromodulators Injectable Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Neuromodulators Injectable Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Neuromodulators Injectable Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Neuromodulators Injectable Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Neuromodulators Injectable Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Neuromodulators Injectable Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Neuromodulators Injectable Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Neuromodulators Injectable Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Neuromodulators Injectable Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Neuromodulators Injectable Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Neuromodulators Injectable Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Neuromodulators Injectable Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Neuromodulators Injectable Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Neuromodulators Injectable Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Neuromodulators Injectable Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Neuromodulators Injectable Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Neuromodulators Injectable Revenue, (US$, Mn), 2022-2027
Table 30. ALLERGAN Corporate Summary
Table 31. ALLERGAN Neuromodulators Injectable Product Offerings
Table 32. ALLERGAN Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 33. Merz Pharma Corporate Summary
Table 34. Merz Pharma Neuromodulators Injectable Product Offerings
Table 35. Merz Pharma Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 36. Suneva Medical Corporate Summary
Table 37. Suneva Medical Neuromodulators Injectable Product Offerings
Table 38. Suneva Medical Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 39. Medytox Corporate Summary
Table 40. Medytox Neuromodulators Injectable Product Offerings
Table 41. Medytox Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 42. Sinclair Pharma Corporate Summary
Table 43. Sinclair Pharma Neuromodulators Injectable Product Offerings
Table 44. Sinclair Pharma Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 45. Bloomage BioTechnology Corporation Limited Corporate Summary
Table 46. Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Product Offerings
Table 47. Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 48. Anika Therapeutics Corporate Summary
Table 49. Anika Therapeutics Neuromodulators Injectable Product Offerings
Table 50. Anika Therapeutics Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 51. Galderma Corporate Summary
Table 52. Galderma Neuromodulators Injectable Product Offerings
Table 53. Galderma Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 54. Bausch Health Companies Corporate Summary
Table 55. Bausch Health Companies Neuromodulators Injectable Product Offerings
Table 56. Bausch Health Companies Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)
Table 57. Integra Lifesciences Corporate Summary
Table 58. Integra Lifesciences Neuromodulators Injectable Product Offerings
Table 59. Integra Lifesciences Neuromodulators Injectable Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Neuromodulators Injectable Segment by Type
Figure 2. Neuromodulators Injectable Segment by Application
Figure 3. Global Neuromodulators Injectable Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Neuromodulators Injectable Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Neuromodulators Injectable Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuromodulators Injectable Revenue in 2020
Figure 8. By Type - Global Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 9. By Application - Global Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 10. By Region - Global Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 11. By Country - North America Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 12. US Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 16. Germany Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 17. France Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 24. China Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 28. India Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 30. Brazil Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Neuromodulators Injectable Revenue Market Share, 2016-2027
Figure 33. Turkey Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Neuromodulators Injectable Revenue, (US$, Mn), 2016-2027
Figure 37. ALLERGAN Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merz Pharma Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Suneva Medical Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Medytox Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sinclair Pharma Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Anika Therapeutics Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Galderma Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bausch Health Companies Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Integra Lifesciences Neuromodulators Injectable Revenue Year Over Year Growth (US$, Mn) & (2016-2021)